Industry Research Reports

Home > Reports > Medical Care > Stem Cell Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Stem Cell Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Medical Care

Published Date: 2026-01-04

Pages: 131 Pages

Report ld: 5493032

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Stem Cell Therapy Market Size(US$)

CAGR 2026-2032

19.7%

Market Size,2032

USD 2,793

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 950 million

Market Forecast in 2032(Value)

US$ 2,793 million

CAGR

19.7%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Stem Cell Therapy was estimated to be worth US$ 807 million in 2025 and is projected to reach US$ 2793 million, growing at a CAGR of 19.7% from 2026 to 2032.

Stem cell therapy refers to the use of stem cells to treat or prevent a disease or condition. These cells can differentiate into various specialized cell types, offering potential for regenerating damaged tissues, modulating immune responses, and restoring normal function in affected organs. Downstream applications include treatment for neurodegenerative diseases, cardiovascular disorders, autoimmune conditions, orthopedic injuries, and certain cancers.

The global stem cell therapy market has been gaining momentum due to increasing demand for regenerative medicine and technological advancements in cell-based research. Governments and private sectors are actively investing in clinical trials, research infrastructure, and commercialization strategies. There is a rising incidence of chronic and degenerative diseases, such as Parkinson’s disease, type 1 diabetes, and heart failure, which are driving the adoption of stem cell-based treatments. Moreover, increasing awareness among patients and healthcare professionals about the potential of stem cell therapy is accelerating clinical adoption. Regulatory frameworks are gradually evolving to accommodate the unique aspects of stem cell research, though regional disparities in regulation and ethical concerns still pose challenges. Academic institutions, biotechnology companies, and hospitals are collaborating to translate laboratory research into clinical applications. With continued innovation, the market is expected to expand into personalized medicine, particularly with the integration of gene editing technologies and induced pluripotent stem cells (iPSCs).

This report provides a comprehensive view of the global market for Stem Cell Therapy, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Stem Cell Therapy market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Stem Cell Therapy.

MARKET SEGMENTATION

By Company

Medipost
Theracell Advanced Biotechnology
Nature Cell
Stempeutics
Regeneus
Bluebird bio, Inc
NIPRO
Kyowa Kirin
CorestemChemon Inc.
ANTEROGEN.CO., LTD.
Holostem
NuVasive
JCR Pharmaceutical
Pharmicell
Medi-post
Anterogen
Takeda (TiGenix)

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Allogeneic Stem Cell Therapies
Autologous Stem Cell Therapies

Segment by Application

Neurodegenerative Diseases
Cardiovascular Disorders
Autoimmune Conditions
Orthopedic Injuries
Cancer
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the Stem Cell Therapy companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Stem Cell Therapy revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Stem Cell Therapy revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Stem Cell Therapy Product Introduction

1.2 Global Stem Cell Therapy Market Size Forecast (2021–2032)

1.3 Stem Cell Therapy Market Trends & Drivers

1.3.1 Stem Cell Therapy Industry Trends

1.3.2 Stem Cell Therapy Market Drivers & Opportunities

1.3.3 Stem Cell Therapy Market Challenges

1.3.4 Stem Cell Therapy Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Stem Cell Therapy Players Revenue Ranking (2025)

2.2 Global Stem Cell Therapy Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies Stem Cell Therapy Product Offerings

2.5 Key Companies General Availability (GA) Timeline for Stem Cell Therapy

2.6 Stem Cell Therapy Market Competitive Analysis

2.6.1 Stem Cell Therapy Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by Stem Cell Therapy Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Stem Cell Therapy revenue, 2025

2.7 Mergers & Acquisitions and Expansion

3 Segmentation Stem Cell Therapy Market Classification

3.1 Introduction by Type

3.1.1 Allogeneic Stem Cell Therapies

3.1.2 Autologous Stem Cell Therapies

3.1.3 Global Stem Cell Therapy Sales Value by Type

3.1.3.1 Global Stem Cell Therapy Sales Value by Type (2021 vs 2025 vs 2032)

3.1.3.2 Global Stem Cell Therapy Sales Value, by Type (2021–2032)

3.1.3.3 Global Stem Cell Therapy Sales Value, by Type (%), 2021–2032

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Neurodegenerative Diseases

4.1.2 Cardiovascular Disorders

4.1.3 Autoimmune Conditions

4.1.4 Orthopedic Injuries

4.1.5 Cancer

4.1.6 Others

4.2 Global Stem Cell Therapy Sales Value by Application

4.2.1 Global Stem Cell Therapy Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Stem Cell Therapy Sales Value by Application (2021–2032)

4.2.3 Global Stem Cell Therapy Sales Value by Application (%), 2021–2032

5 Segmentation by Region

5.1 Global Stem Cell Therapy Sales Value by Region

5.1.1 Global Stem Cell Therapy Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Stem Cell Therapy Sales Value by Region (2021–2026)

5.1.3 Global Stem Cell Therapy Sales Value by Region (2027–2032)

5.1.4 Global Stem Cell Therapy Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America Stem Cell Therapy Sales Value, 2021–2032

5.2.2 North America Stem Cell Therapy Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe Stem Cell Therapy Sales Value, 2021–2032

5.3.2 Europe Stem Cell Therapy Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific Stem Cell Therapy Sales Value, 2021–2032

5.4.2 Asia Pacific Stem Cell Therapy Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America Stem Cell Therapy Sales Value, 2021–2032

5.5.2 South America Stem Cell Therapy Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa Stem Cell Therapy Sales Value, 2021–2032

5.6.2 Middle East & Africa Stem Cell Therapy Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Stem Cell Therapy Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Stem Cell Therapy Sales Value, 2021–2032

6.3 United States

6.3.1 United States Stem Cell Therapy Sales Value, 2021–2032

6.3.2 United States Stem Cell Therapy Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Stem Cell Therapy Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Stem Cell Therapy Sales Value, 2021–2032

6.4.2 Europe Stem Cell Therapy Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Stem Cell Therapy Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Stem Cell Therapy Sales Value, 2021–2032

6.5.2 China Stem Cell Therapy Sales Value by Type (%), 2025 vs 2032

6.5.3 China Stem Cell Therapy Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Stem Cell Therapy Sales Value, 2021–2032

6.6.2 Japan Stem Cell Therapy Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Stem Cell Therapy Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Stem Cell Therapy Sales Value, 2021–2032

6.7.2 South Korea Stem Cell Therapy Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Stem Cell Therapy Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Stem Cell Therapy Sales Value, 2021–2032

6.8.2 Southeast Asia Stem Cell Therapy Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Stem Cell Therapy Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Stem Cell Therapy Sales Value, 2021–2032

6.9.2 India Stem Cell Therapy Sales Value by Type (%), 2025 vs 2032

6.9.3 India Stem Cell Therapy Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Medipost

7.1.1 Medipost Profile

7.1.2 Medipost Main Business

7.1.3 Medipost Stem Cell Therapy Products, Services, and Solutions

7.1.4 Medipost Stem Cell Therapy Revenue (US$ Million), 2021–2026

7.1.5 Medipost Recent Developments

7.2 Theracell Advanced Biotechnology

7.2.1 Theracell Advanced Biotechnology Profile

7.2.2 Theracell Advanced Biotechnology Main Business

7.2.3 Theracell Advanced Biotechnology Stem Cell Therapy Products, Services, and Solutions

7.2.4 Theracell Advanced Biotechnology Stem Cell Therapy Revenue (US$ Million), 2021–2026

7.2.5 Theracell Advanced Biotechnology Recent Developments

7.3 Nature Cell

7.3.1 Nature Cell Profile

7.3.2 Nature Cell Main Business

7.3.3 Nature Cell Stem Cell Therapy Products, Services, and Solutions

7.3.4 Nature Cell Stem Cell Therapy Revenue (US$ Million), 2021–2026

7.3.5 Nature Cell Recent Developments

7.4 Stempeutics

7.4.1 Stempeutics Profile

7.4.2 Stempeutics Main Business

7.4.3 Stempeutics Stem Cell Therapy Products, Services, and Solutions

7.4.4 Stempeutics Stem Cell Therapy Revenue (US$ Million), 2021–2026

7.4.5 Stempeutics Recent Developments

7.5 Regeneus

7.5.1 Regeneus Profile

7.5.2 Regeneus Main Business

7.5.3 Regeneus Stem Cell Therapy Products, Services, and Solutions

7.5.4 Regeneus Stem Cell Therapy Revenue (US$ Million), 2021–2026

7.5.5 Regeneus Recent Developments

7.6 Bluebird bio, Inc

7.6.1 Bluebird bio, Inc Profile

7.6.2 Bluebird bio, Inc Main Business

7.6.3 Bluebird bio, Inc Stem Cell Therapy Products, Services, and Solutions

7.6.4 Bluebird bio, Inc Stem Cell Therapy Revenue (US$ Million), 2021–2026

7.6.5 Bluebird bio, Inc Recent Developments

7.7 NIPRO

7.7.1 NIPRO Profile

7.7.2 NIPRO Main Business

7.7.3 NIPRO Stem Cell Therapy Products, Services, and Solutions

7.7.4 NIPRO Stem Cell Therapy Revenue (US$ Million), 2021–2026

7.7.5 NIPRO Recent Developments

7.8 Kyowa Kirin

7.8.1 Kyowa Kirin Profile

7.8.2 Kyowa Kirin Main Business

7.8.3 Kyowa Kirin Stem Cell Therapy Products, Services, and Solutions

7.8.4 Kyowa Kirin Stem Cell Therapy Revenue (US$ Million), 2021–2026

7.8.5 Kyowa Kirin Recent Developments

7.9 CorestemChemon Inc.

7.9.1 CorestemChemon Inc. Profile

7.9.2 CorestemChemon Inc. Main Business

7.9.3 CorestemChemon Inc. Stem Cell Therapy Products, Services, and Solutions

7.9.4 CorestemChemon Inc. Stem Cell Therapy Revenue (US$ Million), 2021–2026

7.9.5 CorestemChemon Inc. Recent Developments

7.10 ANTEROGEN.CO., LTD.

7.10.1 ANTEROGEN.CO., LTD. Profile

7.10.2 ANTEROGEN.CO., LTD. Main Business

7.10.3 ANTEROGEN.CO., LTD. Stem Cell Therapy Products, Services, and Solutions

7.10.4 ANTEROGEN.CO., LTD. Stem Cell Therapy Revenue (US$ Million), 2021–2026

7.10.5 ANTEROGEN.CO., LTD. Recent Developments

7.11 Holostem

7.11.1 Holostem Profile

7.11.2 Holostem Main Business

7.11.3 Holostem Stem Cell Therapy Products, Services, and Solutions

7.11.4 Holostem Stem Cell Therapy Revenue (US$ Million), 2021–2026

7.11.5 Holostem Recent Developments

7.12 NuVasive

7.12.1 NuVasive Profile

7.12.2 NuVasive Main Business

7.12.3 NuVasive Stem Cell Therapy Products, Services, and Solutions

7.12.4 NuVasive Stem Cell Therapy Revenue (US$ Million), 2021–2026

7.12.5 NuVasive Recent Developments

7.13 JCR Pharmaceutical

7.13.1 JCR Pharmaceutical Profile

7.13.2 JCR Pharmaceutical Main Business

7.13.3 JCR Pharmaceutical Stem Cell Therapy Products, Services, and Solutions

7.13.4 JCR Pharmaceutical Stem Cell Therapy Revenue (US$ Million), 2021–2026

7.13.5 JCR Pharmaceutical Recent Developments

7.14 Pharmicell

7.14.1 Pharmicell Profile

7.14.2 Pharmicell Main Business

7.14.3 Pharmicell Stem Cell Therapy Products, Services, and Solutions

7.14.4 Pharmicell Stem Cell Therapy Revenue (US$ Million), 2021–2026

7.14.5 Pharmicell Recent Developments

7.15 Medi-post

7.15.1 Medi-post Profile

7.15.2 Medi-post Main Business

7.15.3 Medi-post Stem Cell Therapy Products, Services, and Solutions

7.15.4 Medi-post Stem Cell Therapy Revenue (US$ Million), 2021–2026

7.15.5 Medi-post Recent Developments

7.16 Anterogen

7.16.1 Anterogen Profile

7.16.2 Anterogen Main Business

7.16.3 Anterogen Stem Cell Therapy Products, Services, and Solutions

7.16.4 Anterogen Stem Cell Therapy Revenue (US$ Million), 2021–2026

7.16.5 Anterogen Recent Developments

7.17 Takeda (TiGenix)

7.17.1 Takeda (TiGenix) Profile

7.17.2 Takeda (TiGenix) Main Business

7.17.3 Takeda (TiGenix) Stem Cell Therapy Products, Services, and Solutions

7.17.4 Takeda (TiGenix) Stem Cell Therapy Revenue (US$ Million), 2021–2026

7.17.5 Takeda (TiGenix) Recent Developments

8 Industry Chain Analysis

8.1 Stem Cell Therapy Value Chain

8.2 Stem Cell Therapy Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 Stem Cell Therapy Sales Model

8.5.2 Sales Channels

8.5.3 Stem Cell Therapy Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Stem Cell Therapy Market Trends

Table 2. Stem Cell Therapy Market Drivers & Opportunities

Table 3. Stem Cell Therapy Market Challenges

Table 4. Stem Cell Therapy Market Restraints

Table 5. Global Stem Cell Therapy Revenue by Company (US$ Million), 2021–2026

Table 6. Global Stem Cell Therapy Revenue Market Share by Company (2021–2026)

Table 7. Key Companies’ R&D and Operations Footprint and Headquarters

Table 8. Key Companies Stem Cell Therapy Product Type

Table 9. Key Companies General Availability (GA) Timeline for Stem Cell Therapy

Table 10. Global Stem Cell Therapy Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Stem Cell Therapy revenue, 2025

Table 12. Mergers & Acquisitions and Expansion Plans

Table 13. Global Stem Cell Therapy Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 14. Global Stem Cell Therapy Sales Value by Type (US$ Million), 2021–2026

Table 15. Global Stem Cell Therapy Sales Value by Type (US$ Million), 2027–2032

Table 16. Global Stem Cell Therapy Sales Market Share in Value by Type (2021–2026)

Table 17. Global Stem Cell Therapy Sales Market Share in Value by Type (2027–2032)

Table 18. Global Stem Cell Therapy Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 19. Global Stem Cell Therapy Sales Value by Application (US$ Million), 2021–2026

Table 20. Global Stem Cell Therapy Sales Value by Application (US$ Million), 2027–2032

Table 21. Global Stem Cell Therapy Sales Market Share in Value by Application (2021–2026)

Table 22. Global Stem Cell Therapy Sales Market Share in Value by Application (2027–2032)

Table 23. Global Stem Cell Therapy Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 24. Global Stem Cell Therapy Sales Value by Region (US$ Million), 2021–2026

Table 25. Global Stem Cell Therapy Sales Value by Region (US$ Million), 2027–2032

Table 26. Global Stem Cell Therapy Sales Value by Region (%), 2021–2026

Table 27. Global Stem Cell Therapy Sales Value by Region (%), 2027–2032

Table 28. Key Countries/Regions Stem Cell Therapy Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 29. Key Countries/Regions Stem Cell Therapy Sales Value, (US$ Million), 2021–2026

Table 30. Key Countries/Regions Stem Cell Therapy Sales Value, (US$ Million), 2027–2032

Table 31. Medipost Basic Information List

Table 32. Medipost Description and Business Overview

Table 33. Medipost Stem Cell Therapy Products, Services, and Solutions

Table 34. Revenue (US$ Million) in Stem Cell Therapy Business of Medipost (2021–2026)

Table 35. Medipost Recent Developments

Table 36. Theracell Advanced Biotechnology Basic Information List

Table 37. Theracell Advanced Biotechnology Description and Business Overview

Table 38. Theracell Advanced Biotechnology Stem Cell Therapy Products, Services, and Solutions

Table 39. Revenue (US$ Million) in Stem Cell Therapy Business of Theracell Advanced Biotechnology (2021–2026)

Table 40. Theracell Advanced Biotechnology Recent Developments

Table 41. Nature Cell Basic Information List

Table 42. Nature Cell Description and Business Overview

Table 43. Nature Cell Stem Cell Therapy Products, Services, and Solutions

Table 44. Revenue (US$ Million) in Stem Cell Therapy Business of Nature Cell (2021–2026)

Table 45. Nature Cell Recent Developments

Table 46. Stempeutics Basic Information List

Table 47. Stempeutics Description and Business Overview

Table 48. Stempeutics Stem Cell Therapy Products, Services, and Solutions

Table 49. Revenue (US$ Million) in Stem Cell Therapy Business of Stempeutics (2021–2026)

Table 50. Stempeutics Recent Developments

Table 51. Regeneus Basic Information List

Table 52. Regeneus Description and Business Overview

Table 53. Regeneus Stem Cell Therapy Products, Services, and Solutions

Table 54. Revenue (US$ Million) in Stem Cell Therapy Business of Regeneus (2021–2026)

Table 55. Regeneus Recent Developments

Table 56. Bluebird bio, Inc Basic Information List

Table 57. Bluebird bio, Inc Description and Business Overview

Table 58. Bluebird bio, Inc Stem Cell Therapy Products, Services, and Solutions

Table 59. Revenue (US$ Million) in Stem Cell Therapy Business of Bluebird bio, Inc (2021–2026)

Table 60. Bluebird bio, Inc Recent Developments

Table 61. NIPRO Basic Information List

Table 62. NIPRO Description and Business Overview

Table 63. NIPRO Stem Cell Therapy Products, Services, and Solutions

Table 64. Revenue (US$ Million) in Stem Cell Therapy Business of NIPRO (2021–2026)

Table 65. NIPRO Recent Developments

Table 66. Kyowa Kirin Basic Information List

Table 67. Kyowa Kirin Description and Business Overview

Table 68. Kyowa Kirin Stem Cell Therapy Products, Services, and Solutions

Table 69. Revenue (US$ Million) in Stem Cell Therapy Business of Kyowa Kirin (2021–2026)

Table 70. Kyowa Kirin Recent Developments

Table 71. CorestemChemon Inc. Basic Information List

Table 72. CorestemChemon Inc. Description and Business Overview

Table 73. CorestemChemon Inc. Stem Cell Therapy Products, Services, and Solutions

Table 74. Revenue (US$ Million) in Stem Cell Therapy Business of CorestemChemon Inc. (2021–2026)

Table 75. CorestemChemon Inc. Recent Developments

Table 76. ANTEROGEN.CO., LTD. Basic Information List

Table 77. ANTEROGEN.CO., LTD. Description and Business Overview

Table 78. ANTEROGEN.CO., LTD. Stem Cell Therapy Products, Services, and Solutions

Table 79. Revenue (US$ Million) in Stem Cell Therapy Business of ANTEROGEN.CO., LTD. (2021–2026)

Table 80. ANTEROGEN.CO., LTD. Recent Developments

Table 81. Holostem Basic Information List

Table 82. Holostem Description and Business Overview

Table 83. Holostem Stem Cell Therapy Products, Services, and Solutions

Table 84. Revenue (US$ Million) in Stem Cell Therapy Business of Holostem (2021–2026)

Table 85. Holostem Recent Developments

Table 86. NuVasive Basic Information List

Table 87. NuVasive Description and Business Overview

Table 88. NuVasive Stem Cell Therapy Products, Services, and Solutions

Table 89. Revenue (US$ Million) in Stem Cell Therapy Business of NuVasive (2021–2026)

Table 90. NuVasive Recent Developments

Table 91. JCR Pharmaceutical Basic Information List

Table 92. JCR Pharmaceutical Description and Business Overview

Table 93. JCR Pharmaceutical Stem Cell Therapy Products, Services, and Solutions

Table 94. Revenue (US$ Million) in Stem Cell Therapy Business of JCR Pharmaceutical (2021–2026)

Table 95. JCR Pharmaceutical Recent Developments

Table 96. Pharmicell Basic Information List

Table 97. Pharmicell Description and Business Overview

Table 98. Pharmicell Stem Cell Therapy Products, Services, and Solutions

Table 99. Revenue (US$ Million) in Stem Cell Therapy Business of Pharmicell (2021–2026)

Table 100. Pharmicell Recent Developments

Table 101. Medi-post Basic Information List

Table 102. Medi-post Description and Business Overview

Table 103. Medi-post Stem Cell Therapy Products, Services, and Solutions

Table 104. Revenue (US$ Million) in Stem Cell Therapy Business of Medi-post (2021–2026)

Table 105. Medi-post Recent Developments

Table 106. Anterogen Basic Information List

Table 107. Anterogen Description and Business Overview

Table 108. Anterogen Stem Cell Therapy Products, Services, and Solutions

Table 109. Revenue (US$ Million) in Stem Cell Therapy Business of Anterogen (2021–2026)

Table 110. Anterogen Recent Developments

Table 111. Takeda (TiGenix) Basic Information List

Table 112. Takeda (TiGenix) Description and Business Overview

Table 113. Takeda (TiGenix) Stem Cell Therapy Products, Services, and Solutions

Table 114. Revenue (US$ Million) in Stem Cell Therapy Business of Takeda (TiGenix) (2021–2026)

Table 115. Takeda (TiGenix) Recent Developments

Table 116. Revenue (US$ Million) in Stem Cell Therapy Business of Company 40 (2021–2026)

Table 117. Company 40 Recent Developments

Table 118. Key Raw Materials Lists

Table 119. Key Suppliers of Raw Materials Lists

Table 120. Stem Cell Therapy Downstream Customers

Table 121. Stem Cell Therapy Distributors List

Table 122. Research Programs/Design for This Report

Table 123. Key Data Information from Secondary Sources

Table 124. Key Data Information from Primary Sources

List of Figures

Figure 1. Stem Cell Therapy Product Picture

Figure 2. Global Stem Cell Therapy Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Stem Cell Therapy Sales Value (US$ Million), 2021–2032

Figure 4. Stem Cell Therapy Report Years Considered

Figure 5. Global Stem Cell Therapy Players Revenue Ranking (US$ Million), 2025

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Stem Cell Therapy Revenue in 2025

Figure 7. Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 8. Allogeneic Stem Cell Therapies Picture

Figure 9. Autologous Stem Cell Therapies Picture

Figure 10. Global Stem Cell Therapy Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 11. Global Stem Cell Therapy Sales Value Market Share by Type, 2025 & 2032

Figure 12. Product Picture of Neurodegenerative Diseases

Figure 13. Product Picture of Cardiovascular Disorders

Figure 14. Product Picture of Autoimmune Conditions

Figure 15. Product Picture of Orthopedic Injuries

Figure 16. Product Picture of Cancer

Figure 17. Product Picture of Others

Figure 18. Global Stem Cell Therapy Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 19. Global Stem Cell Therapy Sales Value Market Share by Application, 2025 & 2032

Figure 20. North America Stem Cell Therapy Sales Value (US$ Million), 2021–2032

Figure 21. North America Stem Cell Therapy Sales Value by Country (%), 2025 vs 2032

Figure 22. Europe Stem Cell Therapy Sales Value (US$ Million), 2021–2032

Figure 23. Europe Stem Cell Therapy Sales Value by Country (%), 2025 vs 2032

Figure 24. Asia Pacific Stem Cell Therapy Sales Value (US$ Million), 2021–2032

Figure 25. Asia Pacific Stem Cell Therapy Sales Value by Subregion (%), 2025 vs 2032

Figure 26. South America Stem Cell Therapy Sales Value (US$ Million), 2021–2032

Figure 27. South America Stem Cell Therapy Sales Value by Country (%), 2025 vs 2032

Figure 28. Middle East & Africa Stem Cell Therapy Sales Value (US$ Million), 2021–2032

Figure 29. Middle East & Africa Stem Cell Therapy Sales Value by Country (%), 2025 vs 2032

Figure 30. Key Countries/Regions Stem Cell Therapy Sales Value (%), 2021–2032

Figure 31. United States Stem Cell Therapy Sales Value (US$ Million), 2021–2032

Figure 32. United States Stem Cell Therapy Sales Value by Type (%), 2025 vs 2032

Figure 33. United States Stem Cell Therapy Sales Value by Application (%), 2025 vs 2032

Figure 34. Europe Stem Cell Therapy Sales Value (US$ Million), 2021–2032

Figure 35. Europe Stem Cell Therapy Sales Value by Type (%), 2025 vs 2032

Figure 36. Europe Stem Cell Therapy Sales Value by Application (%), 2025 vs 2032

Figure 37. China Stem Cell Therapy Sales Value (US$ Million), 2021–2032

Figure 38. China Stem Cell Therapy Sales Value by Type (%), 2025 vs 2032

Figure 39. China Stem Cell Therapy Sales Value by Application (%), 2025 vs 2032

Figure 40. Japan Stem Cell Therapy Sales Value (US$ Million), 2021–2032

Figure 41. Japan Stem Cell Therapy Sales Value by Type (%), 2025 vs 2032

Figure 42. Japan Stem Cell Therapy Sales Value by Application (%), 2025 vs 2032

Figure 43. South Korea Stem Cell Therapy Sales Value (US$ Million), 2021–2032

Figure 44. South Korea Stem Cell Therapy Sales Value by Type (%), 2025 vs 2032

Figure 45. South Korea Stem Cell Therapy Sales Value by Application (%), 2025 vs 2032

Figure 46. Southeast Asia Stem Cell Therapy Sales Value (US$ Million), 2021–2032

Figure 47. Southeast Asia Stem Cell Therapy Sales Value by Type (%), 2025 vs 2032

Figure 48. Southeast Asia Stem Cell Therapy Sales Value by Application (%), 2025 vs 2032

Figure 49. India Stem Cell Therapy Sales Value (US$ Million), 2021–2032

Figure 50. India Stem Cell Therapy Sales Value by Type (%), 2025 vs 2032

Figure 51. India Stem Cell Therapy Sales Value by Application (%), 2025 vs 2032

Figure 52. Stem Cell Therapy Value Chain

Figure 53. Stem Cell Therapy Cost Structure

Figure 54. Channels of Distribution (Direct Sales, and Distribution)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share? zhanKai

For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 19.7% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.

What is the annual compound growth rate of the global Stem Cell Therapy market size from 2026 to 2032? shouQi

What was the global market size of Stem Cell Therapy in 2032? shouQi

Which companies rank high in the global Stem Cell Therapy market? shouQi

What was the global market size of Stem Cell Therapy in 2026? shouQi

Related Reports

Global Stem Cell Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Stem Cell Therapy market size was US$ 807 million in 2025 and is forecast to reach a readjusted size of US$ 2793 million by 2032 with a CAGR of 19.7% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 105
USD 4250.00
(Single User License)
Global Stem Cell Therapy Market Research Report 2026
The global Stem Cell Therapy market was valued at US$ 807 million in 2025 and is anticipated to reach US$ 2793 million by 2032, at a CAGR of 19.7% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 139
USD 2900.00
(Single User License)
Stem Cell Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Stem Cell Therapy was estimated to be worth US$ 685 million in 2024 and is forecast to a readjusted size of US$ 2373 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031.
Published Date: 2025-10-16
Pages: 123
USD 3950.00
(Single User License)
Global Stem Cell Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Stem Cell Therapy market is projected to grow from US$ 685 million in 2024 to US$ 2373 million by 2031, at a CAGR of 19.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-09-11
Pages: 149
USD 4900.00
(Single User License)
Global Stem Cell Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Stem Cell Therapy market size was US$ 685 million in 2024 and is forecast to a readjusted size of US$ 2373 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031.
Published Date: 2025-09-08
Pages: 110
USD 4250.00
(Single User License)
Global Stem Cell Therapy Market Research Report 2025
The global market for Stem Cell Therapy was valued at US$ 685 million in the year 2024 and is projected to reach a revised size of US$ 2373 million by 2031, growing at a CAGR of 19.7% during the forecast period.
Published Date: 2025-09-08
Pages: 99
USD 2900.00
(Single User License)
Global Stem Cell Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Stem Cell Therapy was estimated to be worth US$ 685 million and is forecast to reach approximately US$ 2373 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 130
USD 5900.00
(Single User License)
Stem Cell Therapy- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Stem Cell Therapy was estimated to be worth US$ 685 million in 2024 and is forecast to a readjusted size of US$ 2373 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 93
USD 3950.00
(Single User License)
Global Stem Cell Therapy Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
Published Date: 2024-04-17
Pages: 140
USD 5600.00
(Single User License)
Global Stem Cell Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
Published Date: 2024-04-16
Pages: 122
USD 5900.00
(Single User License)

Global Stem Cell Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Stem Cell Therapy market size was US$ 807 million in 2025 and is forecast to reach a readjusted size of US$ 2793 million by 2032 with a CAGR of 19.7% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 105
USD 4250.00 (Single User License)
Global Stem Cell Therapy Market Research Report 2026
The global Stem Cell Therapy market was valued at US$ 807 million in 2025 and is anticipated to reach US$ 2793 million by 2032, at a CAGR of 19.7% from 2026 to 2032.
Published: 2026-01-04
Pages: 139
USD 2900.00 (Single User License)
Stem Cell Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Stem Cell Therapy was estimated to be worth US$ 685 million in 2024 and is forecast to a readjusted size of US$ 2373 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031.
Published: 2025-10-16
Pages: 123
USD 3950.00 (Single User License)
Global Stem Cell Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Stem Cell Therapy market is projected to grow from US$ 685 million in 2024 to US$ 2373 million by 2031, at a CAGR of 19.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-11
Pages: 149
USD 4900.00 (Single User License)
Global Stem Cell Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Stem Cell Therapy market size was US$ 685 million in 2024 and is forecast to a readjusted size of US$ 2373 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031.
Published: 2025-09-08
Pages: 110
USD 4250.00 (Single User License)
Global Stem Cell Therapy Market Research Report 2025
The global market for Stem Cell Therapy was valued at US$ 685 million in the year 2024 and is projected to reach a revised size of US$ 2373 million by 2031, growing at a CAGR of 19.7% during the forecast period.
Published: 2025-09-08
Pages: 99
USD 2900.00 (Single User License)
Global Stem Cell Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Stem Cell Therapy was estimated to be worth US$ 685 million and is forecast to reach approximately US$ 2373 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 130
USD 5900.00 (Single User License)
Stem Cell Therapy- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Stem Cell Therapy was estimated to be worth US$ 685 million in 2024 and is forecast to a readjusted size of US$ 2373 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 93
USD 3950.00 (Single User License)
Global Stem Cell Therapy Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
Published: 2024-04-17
Pages: 140
USD 5600.00 (Single User License)
Global Stem Cell Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
Published: 2024-04-16
Pages: 122
USD 5900.00 (Single User License)